COMP <GO>
PVH vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
PVH Corp. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: PVH 4
— TMO 8
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $92.92 (+3.03%) • MKT CAP: $4.16B
balance-sheet
2.11
LAST: $682.65 (-2.06%) • MKT CAP: $257.71B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PVH VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PVH | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 57.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 9.30% | -6.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.1x | 30.4x | -14.30 | PVH | /valuation <GO> |
| Free Cash Flow Yield | 13.22% | 2.40% | +10.82 | PVH | /fcf-yield <GO> |
| Operating Margin | 2.60% | 17.40% | -14.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 0.30% | 15.10% | -14.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 3.40% | 3.90% | -0.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.11 | 4.50 | -2.39 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.0 | 56.8 | +11.20 | PVH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.94 | +0.14 | PVH | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.16B | $257.71B | -$253.55B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PVH REV | TMO REV | PVH GROSS % | TMO GROSS % | PVH FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.95B | $44.56B | 57.5% | — | $538.4M | $6.29B |
| FY 2024 | $8.65B | $42.88B | 59.4% | — | $582.2M | $7.27B |
| FY 2023 | $9.22B | $42.86B | — | — | $554.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PVH // BETA 1.08
TMO // BETA 0.94